By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Key Statistics

Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO


UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient


Company News
The Medicines Company (MDCO) Receives European Commission (EC) Approval For IONSYS 40 Micrograms Per Dose Transdermal System (Fentanyl) To Treat Post-Operative Pain In Adult Hospitalized Patients 11/20/2015 11:59:47 AM
Federal Circuit Overturns District Court Decision On Angiomax Patents; Grants The Medicines Company (MDCO)’s Request For Rehearing Of Appeal 11/16/2015 12:18:55 PM
Alnylam (ALNY) And The Medicines Company (MDCO) Announce That New ALN-Pcssc Results From Late-Breaking Presentation At AHA Meeting Confirm Potential For Bi-Annual Hypercholesterolemia Dose Regimen 11/11/2015 10:45:56 AM
The Medicines Company (MDCO) To Present New Data On Cardiovascular Portfolio At American Heart Association Scientific Sessions 11/5/2015 1:31:50 PM
The Medicines Company (MDCO) Reports Third-Quarter And First Nine Months 2015 Business And Financial Results 11/3/2015 10:44:24 AM
The Medicines Company (MDCO) Release: Results Of First-In-Man Study With Investigational Anesthetic ABP-700 Presented At ANESTHESIOLOGY® 2015 And International Society Of Anesthetic Pharmacology Annual Meetings 10/27/2015 12:35:07 PM
The Medicines Company (MDCO) To Present Data On Potentially Innovative Surgical Anesthetic At American Society Of Anesthesiologists 2015 Meeting 10/23/2015 10:35:09 AM
The Medicines Company (MDCO) To Announce Third Quarter 2015 Financial Results On Tuesday, November 3, 2015 10/19/2015 11:23:00 AM
The Medicines Company (MDCO) And SymBio Pharmaceuticals Establish Strategic Partnership For IONSYS (Fentanyl Iontophoretic Transdermal System) In Japan 10/7/2015 12:04:24 PM
The Medicines Company (MDCO) Announces BARDA Exercises Next Option On Contract For Support Of The Development Of CARBAVANCE (Meropenem/RPX7009) For Drug-Resistant Gram-Negative Pathogens 10/1/2015 12:48:07 PM